F184-2693 Screening compound: 2,6-dimethyl-7-{[4-(1,2,3,4-tetrahydroquinoline-1-carbonyl)piperidin-1-yl]sulfonyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one

F184-2693 Screening compound: 2,6-dimethyl-7-{[4-(1,2,3,4-tetrahydroquinoline-1-carbonyl)piperidin-1-yl]sulfonyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one
F184-2693 Screening compound: 2,6-dimethyl-7-{[4-(1,2,3,4-tetrahydroquinoline-1-carbonyl)piperidin-1-yl]sulfonyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F184-2693
2,6-dimethyl-7-{[4-(1,2,3,4-tetrahydroquinoline-1-carbonyl)piperidin-1-yl]sulfonyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F184-2693

Molecular Formula

C25H29N3O5S (C25 H29 N3 O5 S)

Compound Name

2,6-dimethyl-7-{[4-(1,2,3,4-tetrahydroquinoline-1-carbonyl)piperidin-1-yl]sulfonyl}-3,4-dihydro-2H-1,4-benzoxazin-3-one

IUPAC name

26-dimethyl-7-{[4-(1234-tetrahydroquinoline-1-carbonyl)piperidin-1-yl]sulfonyl}-34-dihydro-2H-14-benzoxazin-3-one

SMILES

CC1Oc2cc(S(N(CC3)CCC3C(N(CCC3)c4c3cccc4)=O)(=O)=O)c(C)cc2NC1=O

InChI

InChI=1S/C25H29N3O5S/c1-16-14-20-22(33-17(2)24(29)26-20)15-23(16)34(31,32)27-12-9-19(10-13-27)25(30)28-11-5-7-18-6-3-4-8-21(18)28/h3-4,6,8,14-15,17,19H,5,7,9-13H2,1-2H3,(H,26,29)/t17-/m1/s1

InChI Key

AXYXFFKYEPJOCF-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD14944293

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.59

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.115

Distribution Coefficient, logD

3.114

Water Solubility, LogSw

-3.39

Polar Surface Area

79.871

Acid Dissociation Constant (pKa)

10.22

Base Dissociation Constant (pKb)

2.09

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.00

F184-2693 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with F184-2693 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F184-2693?
Check Price and Availability of F184-2693, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F184-2693 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F184-2693
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F184-2693
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F184-2693 available by request